Moderna Inc (NASDAQ:MRNA)
| 173.65 BATS BZX Real-Time Price As of 11:46am ET |  +0.44 / +0.25%Today’s Change | 115.03 Today|||52-Week Range 217.25 | -3.32% Year-to-Date |
Latest MRNA News | Press Releases
| 1 Company Bucks the Office REIT Trend With Higher Rents and Earnings 7:46am / MotleyFool.com - Paid Partner Content | Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Feb 01 / Zacks.com - Paid Partner Content |
| Should Invesco S&P 500 Equal Weight ETF (RSP) Be on Your Investing Radar? 6:20am / Zacks.com - Paid Partner Content | 1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell Feb 01 / MotleyFool.com - Paid Partner Content |
| Top 5 4th Quarter Trades of Lipe & Dalton Feb 03 / GuruFocus News - Paid Partner Content | Top 5 4th Quarter Trades of REIK & CO., LLC Jan 31 / GuruFocus News - Paid Partner Content |
| 3 No-Brainer Growth Stocks to Buy in 2023 Feb 03 / MotleyFool.com - Paid Partner Content | This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now Jan 31 / MotleyFool.com - Paid Partner Content |
| Is Moderna Stock a Buy Now? Feb 03 / MotleyFool.com - Paid Partner Content | Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag Jan 31 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 173.21 |
| Today’s open | 172.21 |
| Day’s range | 169.67 - 174.40 |
| Volume | 58,908 |
| Average volume (3 months) | 5,049,302 |
| Market cap | $66.6B |
Data as of 11:46am ET, 02/06/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -24.57% |
| Earnings growth (next 5 years) | -51.00% |
| Revenue growth (last year) | +2,191.90% |
| P/E ratio | 6.3 |
| Price/Sales | 5.95 |
| Price/Book | 4.94 |
Competitors
Data as of 11:46am ET, 02/06/2023
Financials
| Next reporting date | February 23, 2023 |
| EPS forecast (this quarter) | $4.70 |
| Annual revenue (last year) | $18.4B |
| Annual profit (last year) | $12.2B |
| Net profit margin | 66.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
